SCHEMBL6231327

SCHEMBL6231327

CCN1CCCC1CN(c1ccc(OC)c(F)c1)c1nc(N)nc(OC2CCCCCC2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.35
DRD3 P35462 3/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
SLC6A4 P31645 1/20 0.34
HTR2B P41595 1/20 0.34
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
DRD4 P21917 3/20 0.33
CA2 P00918 2/20 0.33
DRD1 P21728 2/20 0.33
CA9 Q16790 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
MAPT P10636 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA3 P07451 1/20 0.33
ADRA2A P08913 1/20 0.33
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6612950 0.89 DRD2 (0.33) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL6016946 0.85 SMN1; SMN2 (0.44) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL6607362 0.83 GALR1 (0.39) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL6228882 0.83 KDM4E (0.32) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL5554025 0.83 GALR1 (0.38) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL5553593 0.82 DRD2 (0.38) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL6235105 0.81 SMN1; SMN2 (0.34) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL6864393 0.80 DRD2 (0.41) DRD2DRD3ADRA2BADRA2CSLC6A4
SCHEMBL5412204 0.80 KDM4E (0.40) DRD2LMNATSHRRECQLSMN1; SMN2
SCHEMBL5553510 0.79 DRD2 (0.36) DRD2DRD3ADRA2BADRA2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560817-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS Reddy US Therapeutics, Inc. (US) 2005-08-10 EP claimed
WO-2004026844-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS REDDY US THERAPEUTICS, INC. (US) 2004-04-01 WO claimed